product

Description

Humidified high flow nasal cannula therapy is a form of non-invasive respiratory support which has been compared to continuous positive airway pressure (CPAP).

HFNC is a promising novel oxygen delivery device, whose mechanisms of action offer some beneficial effects over conventional oxygen systems. It is considered to have a number of physiological effects: it improves oxygenation, dynamic lung compliance, homogeneity and end expiratory lung volume; it decreases anatomical dead space and generates a positive airway pressure that can reduce respiratory rate, the work of breathing, and enhance patient comfort.

Application

The use of HFNC in patients with Post Surgical Respiratory Failure

The use of HFNC in patients with Acute Heart Failure /Pulmonary edema

 The use of HFNC in patients with Hypercapnic Respiratory Failure, COPD

The use of HFNC in patients with Obstructive Sleep Apnea

Advantage

During the pandemic, micomme provided over 7000 units of devices globally.

At present, micomme occupies over 50% market share in high flow filed in China.

Intelligent temperature and humidity control system.

Effectively reduce the dead space with 70L/min high flow.

High-performance blower and sensor.

Automatic water-adding function to save manual operation.

Specification